Vanderbilt University Institute for Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
J Labelled Comp Radiopharm. 2022 Jun 30;65(8):223-229. doi: 10.1002/jlcr.3975. Epub 2022 May 6.
(R)-[ F]MH.MZ ([ F]MH.MZ) is a promising positron emission tomography (PET) radiotracer for in vivo study of the 5-HT receptor. To facilitate clinical trials, a fully automated radiosynthesis procedure for [ F]MH.MZ was developed using commercially available materials on the iPhase Flexlab module. The overall synthesis time was 100 min with a radiochemical yield of 7 ± 0.9% (n = 3). The radiochemical purity was greater than 99% for [ F]MH.MZ with a molar activity of 361 ± 57 GBq/μmol (n = 3). The protocol described herein reliably provides [ F]MH.MZ that meets all relevant release criteria for a GMP radiopharmaceutical.
(R)-[ F]MH.MZ([ F]MH.MZ)是一种很有前途的正电子发射断层扫描(PET)示踪剂,可用于体内研究 5-HT 受体。为了便于临床试验,使用 iPhase Flexlab 模块上的商业上可获得的材料,开发了一种用于 [ F]MH.MZ 的全自动放射性合成程序。总合成时间为 100 分钟,放射性化学产率为 7±0.9%(n=3)。[ F]MH.MZ 的放射化学纯度大于 99%,摩尔活度为 361±57GBq/μmol(n=3)。本文所述的方案可靠地提供了符合 GMP 放射性药物所有相关放行标准的 [ F]MH.MZ。